MedDataX Logo

Effects of an Oral Multi-vitamin Carbohydrate Beverage on Intraoperative Nausea and Vomiting

NCT ID: NCT06333626

Last Updated: 2024-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-01

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nausea and vomiting are common and unpleasant symptoms for pregnant women during cesarean section, which can lead to aspiration, a serious complication that can cause pneumonia. Our study aimed to evaluate the effects of oral multi-vitamin carbohydrate beverage on maternal intraoperative nausea and vomiting by gastric ultrasound.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section

NCT04069806

Postoperative Nausea and Vomiting
UNKNOWN NA

Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients

NCT01733212

Nausea Vomiting
COMPLETED PHASE2/PHASE3

Effect of Intravenous Metochlopramide Prophylaxis on Gastric Volume

NCT04609124

Aspiration Prophylaxis
COMPLETED

Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean

NCT02959840

Nausea Vomiting Satisfaction
COMPLETED PHASE4

Nausea and Vomiting After Gynecologic Surgery

NCT03795766

Postoperative Nausea and Vomiting Gynecologic Surgery
UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nausea and Vomiting, Aspiration, Intraoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observation group

Group Type EXPERIMENTAL

multi-vitamin carbohydrate

Intervention Type DIETARY_SUPPLEMENT

oral multi-vitamin carbohydrate beverage

Control group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

multi-vitamin carbohydrate

oral multi-vitamin carbohydrate beverage

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at least 37 weeks pregnant, had not eaten for at least 4 h before entering the delivery room, converted from vaginal delivery to cesarean section

Exclusion Criteria

* gestational diabetes mellitus or gastroesophageal reflux disease, cesarean section performed under general anesthesia
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Affiliated Hospital of Soochow University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jinli Xu

Role: CONTACT

[email protected]
+8613812016797

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020281

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Intraoperative Dexamethasone and Ondansetron on Postoperative Nausea and Vomiting in Microvascular Decompression Surgery
NCT03685032 COMPLETED NA
Efficacy of Prevention for Postoperative Nausea and Vomiting After Intrathecal Morphine in Cesarean Section
NCT00892996 UNKNOWN NA
Prevention of Intraoperative Nausea and Vomiting During Cesarean Section
NCT01216410 COMPLETED NA
Risk Factors for Postoperative Nausea and Vomiting in Surgical Patients Undergoing Patient-controlled Intravenous Analgesia.
NCT06226922 COMPLETED
The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting
NCT04742660 COMPLETED NA
Effect of Intravenous Dextrose on PONV in Patients Undergoing Gynecological Laparoscopy
NCT05932160 RECRUITING NA
Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery
NCT03139383 COMPLETED NA
Chewing Gums to Stimulate Intestinal Motility After Cesarean Section
NCT02386748 COMPLETED NA
Granisetron Versus Metoclopramide Effects on Gastric Volume by Sonographic Assessment on Patients Undergoing Caesarean Section.
NCT04290026 UNKNOWN EARLY_PHASE1
Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia
NCT02468323 COMPLETED PHASE4
Preoperative Chewing Gum and Postoperative Nausea and Vomiting
NCT06446583 NOT_YET_RECRUITING NA
Chewing Gum to Prevent Nausea and Vomiting After Caesarean Section Under Spinal Anaesthesia
NCT04191694 UNKNOWN NA
Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section
NCT06254131 COMPLETED NA
Risk Factors for PONV in Patients Undergoing Hysteroscopic Surgery
NCT06524752 COMPLETED
Risk Factors for Post Operative Nausea and Vomiting(PONV) in Patients Underwent Gynecological Operation Under General Anesthesia
NCT01020201 COMPLETED
Carbohydrate Fluids and Post Operative Nausea and Vomiting
NCT06481670 NOT_YET_RECRUITING NA
Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
NCT01482468 UNKNOWN NA
Caffeine in the Prevention of Post-operative Nausea and Vomiting
NCT00130026 COMPLETED NA
Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting
NCT03387956 COMPLETED NA
Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting
NCT02096835 COMPLETED NA
Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections
NCT01734161 COMPLETED PHASE4
Prophylactic Subhypnotic Propofol for Nausea and Vomiting During for Cesarean Section Under Subarachnoid Anesthesia.
NCT01781377 COMPLETED PHASE4
The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting
NCT03626441 COMPLETED PHASE2
The Effect of Oral Honey and Water Up to Two Hours Before Surgery on Postoperative Nausea and Vomiting
NCT04030884 COMPLETED NA
Magnesium Sulfate; Postoperative Nausea and Vomiting; Laparoscopic Surgery
NCT03541915 UNKNOWN NA